Diseases [C] » Eye Diseases [C11] » Eye Diseases, Hereditary
Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Genetic Diseases, Inborn » Eye Diseases, Hereditary
Description
Transmission of gene defects or chromosomal aberrations/abnormalities which are expressed in extreme variation in the structure or function of the eye. These may be evident at birth, but may be manifested later with progression of the disorder. MeSH
Hierarchy View
Subtype Terms (23)
Aicardi Syndrome
5 approved drugs
Albinism
6 drugs (4 approved, 2 experimental)
Aniridia
1 experimental drug
Choroideremia
8 drugs (2 approved, 6 experimental)
Cone-Rod Dystrophies
1 experimental drug
Corneal Dystrophies, Hereditary
3 drugs (2 approved, 1 experimental)
Familial Exudative Vitreoretinopathies
1 approved drug
Graves Ophthalmopathy
59 drugs (41 approved, 18 experimental)
Leber Congenital Amaurosis
14 drugs (6 approved, 8 experimental)
Optic Nerve Hypoplasia
1 experimental drug
Retinal Degeneration
27 drugs (8 approved, 19 experimental)
Retinitis Pigmentosa
66 drugs (18 approved, 48 experimental)
Retinoblastoma
55 drugs (34 approved, 21 experimental)
Stargardt Disease
14 drugs (4 approved, 10 experimental)
Vitelliform Macular Dystrophy
1 approved drug
Phase 2 Indicated Drugs (3)
Phase 1 Indicated Drugs (5)
Other Experimental Indicated Drugs (4)
Organization Involved with Phase 3 Indications (1)
Organization Involved with Phase 2 Indications (5)
Organization Involved with Other Experimental Indications (1)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
